Description
Dart JKG, Papa V, Rama P, et al. The Orphan Drug for Acanthamoeba Keratitis (ODAK) Trial: PHMB 0.08% (Polihexanide) and Placebo versus PHMB 0.02% and Propamidine 0.1. Ophthalmology. Published online October 5, 2023. doi:10.1016/j.ophtha.2023.09.031